Hexagon Bio Revenue and Competitors

Location

#1102

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Hexagon Bio's estimated annual revenue is currently $16.4M per year.(i)
  • Hexagon Bio's estimated revenue per employee is $155,000
  • Hexagon Bio's total funding is $116.3M.

Employee Data

  • Hexagon Bio has 106 Employees.(i)
  • Hexagon Bio grew their employee count by 58% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Our proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.

keywords:Biotechnology

$116.3M

Total Funding

106

Number of Employees

$16.4M

Revenue (est)

58%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Hexagon Bio News

2022-03-22 - Busy Bees: Hexagon Bio Combs Nature's DNA to Unlock Next-Gen ...

Named for the transversely isotropic shape's natural design and engineering properties, Hexagon Bio's proprietary discovery platform enables...

2021-09-22 - Fungi funding: Hexagon Bio snags $61M to test drugs from fungi for cancer, infectious diseases

We all want to be the fungi. Hexagon Bio wants to be the fungi by using those organisms to create new treatments for cancer and infectious diseases, and investors are joining the party with $61 million. That financing adds to the $47 million series A raised nearly a year ago to the day for a ge ...

2021-09-22 - Hexagon Bio : Raises $61 Million to Advance Novel Small-Molecule Medicines Mined from Microbial Genomes

Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, today announced that it has raised $61 million to fuel the continued development of its platform to design and develop new therapeutics mined from microbial genomes. Nextech Invest le ...

2020-09-16 - Hexagon Bio snags $47M

Hexagon Bio has raised a $47 million Series A led by The Column Group, with participation from 8VC and Two Sigma Ventures. The Menlo Park-based biotech startup is developing a molecule discovery platform to help combat cancer and infectious diseases. The company was valued at $33.2 million in 20 ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.2M1099%$45.1M
#2
$15.4M11013%N/A
#3
$22.8M11129%N/A
#4
$35M1127%N/A
#5
$17.5M11355%$48.5M

Hexagon Bio Executives


NameTitle
Tod SmealChief Scientific Officer
Maureen HillenmeyerCEO
Sofia TouamiChief Business Officer
Jim LiVP of Chemistry
Tara ArvedsonSenior Vice President